These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30733187)

  • 1. Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?
    Lonardo A; Ballestri S; Mantovani A; Nascimbeni F; Lugari S; Targher G
    Dig Liver Dis; 2019 Apr; 51(4):462-470. PubMed ID: 30733187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know.
    Bikeyeva V; Abdullah A; Radivojevic A; Abu Jad AA; Ravanavena A; Ravindra C; Igweonu-Nwakile EO; Ali S; Paul S; Yakkali S; Teresa Selvin S; Thomas S; Hamid P
    Cureus; 2022 Aug; 14(8):e28052. PubMed ID: 36127957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research on the natural history of non-alcoholic fatty liver disease should be taken seriously].
    Zhao ZH; Liu XL; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):81-84. PubMed ID: 28297791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Lonardo A
    Adv Ther; 2017 Jun; 34(6):1291-1326. PubMed ID: 28526997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Wu J
    Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.
    Lau JK; Zhang X; Yu J
    J Pathol; 2017 Jan; 241(1):36-44. PubMed ID: 27757953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology.
    Gnocchi D; Custodero C; Sabbà C; Mazzocca A
    J Mol Med (Berl); 2019 Jun; 97(6):741-759. PubMed ID: 30953079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothyroidism and nonalcoholic fatty liver disease - a chance association?
    Lugari S; Mantovani A; Nascimbeni F; Lonardo A
    Horm Mol Biol Clin Investig; 2018 Oct; 41(1):. PubMed ID: 30367792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of non-alcoholic fatty liver disease.
    Bellentani S
    Liver Int; 2017 Jan; 37 Suppl 1():81-84. PubMed ID: 28052624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans.
    Chen K; Ma J; Jia X; Ai W; Ma Z; Pan Q
    Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):117-125. PubMed ID: 30528647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.
    Eshraghian A; Hamidian Jahromi A
    World J Gastroenterol; 2014 Jul; 20(25):8102-9. PubMed ID: 25009382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases.
    Chi HC; Tsai CY; Tsai MM; Yeh CT; Lin KH
    J Biomed Sci; 2019 Mar; 26(1):24. PubMed ID: 30849993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy, NAFLD and NAFLD-Related HCC.
    Wu WKK; Zhang L; Chan MTV
    Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O; Charlton M
    Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of and major animal models used for nonalcoholic fatty liver disease.
    Jiang M; Wu N; Chen X; Wang W; Chu Y; Liu H; Li W; Chen D; Li X; Xu B
    J Int Med Res; 2019 Apr; 47(4):1453-1466. PubMed ID: 30871397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hypothyroidism in nonalcoholic fatty liver disease.
    Pagadala MR; Zein CO; Dasarathy S; Yerian LM; Lopez R; McCullough AJ
    Dig Dis Sci; 2012 Feb; 57(2):528-34. PubMed ID: 22183820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment.
    Argyrou C; Moris D; Vernadakis S
    J BUON; 2017; 22(1):6-20. PubMed ID: 28365930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.